ENTX — ENTERA BIO LTD

Ownership history in XTX Topco Ltd  ·  4 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in ENTERA BIO LTD (ENTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2021 Q1)
Avg. % of fund
0.01%
First filed
2021 Q1
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 10,771 -88 -0.8% 0.00% $21K $1.92
2025 Q1 ADDED 10,859 +426 +4.1% 0.00% $18K $1.70
2021 Q2 REDUCED 10,433 -1,126 -9.7% 0.02% $62K $5.98
2021 Q1 INITIATED 11,559 — — 0.02% $44K $3.81
% of Fund (quarterly)    ENTX price (monthly, adj. close)

Other funds also holding ENTX

As of 2025 Q4 — sorted by position size

Knoll Capital Management, LLC 3Y 7Y 5.23% Seven Fleet Capital Management LP 0.2% Parkman Healthcare Partners LLC 3Y 0.05% SUPERSTRING CAPITAL MANAGEMENT LP 0.02% Schonfeld Strategic Advisors LLC 3Y 7Y 0.01% Point72 Asset Management, L.P. 3Y 7Y 0.0% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.0% MARSHALL WACE, LLP 3Y 7Y 0.0% RENAISSANCE TECHNOLOGIES LLC 3Y 7Y 0.0% HighTower Advisors, LLC 3Y 7Y 0.0%
← Back to XTX Topco Ltd Holdings